EndoArt

History

2024: A factory for the production of endoprostheses was built for 1 billion rubles

On July 24, 2024, it became known that a plant for the production of hip joints was built in St. Petersburg. EndoArt, part of the BSS holding, invested more than ₽1 billion in the project, which made it possible to create modern import-substituting production in record time - in just six months.

According to Farmedprom, the new plant plans to produce up to 35 thousand endoprostheses annually, which will significantly reduce the dependence of Russian healthcare on foreign suppliers. Until recently, more than 90% of large joint endoprosthesis needs were met through import.

source = EndoArt

The project is being implemented within the framework of a consortium created on the initiative of EndoArt. It included the VSMPO-AVISMA Corporation, the Russian Institute of Traumatology and Orthopedics named after Vreden and the Central Research Institute of Structural Materials "Promete." Together, the consortium members plan to ensure the technological sovereignty of Russia in the field of prosthetic and orthopedic industry.

By the time the production was launched, the company's specialists had already prepared the necessary documentation, worked out spraying and polishing technologies, as well as other production processes. In addition, a product strategy has been defined and a mechanism for the supply of finished products has been developed.

Complete localization of hip endoprosthesis production is expected by 2025. After meeting domestic demand, the company is considering entering export markets.

Holding "BSS" also implements the project "Spare parts for humans," within the framework of which it is planned to open serial production facilities for endoprosthetics in Moscow and St. Petersburg. At EndoArt sites, the company intends to develop bioprinting technologies to replace bone defects. The launch of the enterprise is scheduled for August 2024.^[1]

Notes